As of Jun 22
| -0.33 / -1.87%|
The 7 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 39.00 and a low estimate of 18.00. The median estimate represents a +56.07% increase from the last price of 17.30.
The current consensus among 9 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.